Efficacy of GMI, a fungal immunomodulatory protein, for head and neck cancer patients with chemotherapy-related oral mucositis

Efficacy of GMI, a fungal immunomodulatory protein, for head and neck cancer patients with chemotherapy-related oral mucositis

Abstract. Background:. Cancer patients usually suffer from intensive chemotherapy-related oral mucositis (OM), yet limited effective treatment can rapidly alleviate OM severity. Methods:. This prospective study examined the efficacy of Reishimmune-S containing one fungal immunomodulatory protein, GM...

Full description

Bibliographic Details
Main Authors: Hsueh-Ju Lu, MD, PhD, Che-Hsing Li, MD, Yu-Ting Kang, PhD, Chi-Mei Wu, MS, Chih-Hsien Wu, PhD, Jiunn-Liang Ko, PhD, Ming-Fang Wu, MD, PhD, Maya Saranathan.
Format: Article
Language:English
Published: Wolters Kluwer 2022-04-01
Series:Medicine
Online Access:http://journals.lww.com/10.1097/MD.0000000000029185

Internet

http://journals.lww.com/10.1097/MD.0000000000029185

Similar Items